<description>In this episode of The New Frontier podcast, we're joined by Daniel Schulz-Jander, Senior Director of Mass spectrometry Bioanalysis at QPS Netherlands (Groningen). Daniel explains how he uses immune-precipitation and immunoaffinity LC–MS techniques for his work relating to macromolecular pharmaceuticals like gene therapies, as well as their benefits and challenges. Daniel also covers bottom-up, middle-down and top-down approaches and their suitability for his work in clinical support versus research and discovery.</description>

In this episode of The New Frontier podcast, we'r…

In this episode of The New Frontier podcast, we're joined by Daniel Schulz-Jander, Senior Director of Mass spectrometry Bioanalysis at QPS Netherlands (Groningen). Daniel explains how he uses immune-precipitation and immunoaffinity LC–MS techniques for his work relating to macromolecular pharmaceuticals like gene therapies, as well as their benefits and challenges. Daniel also covers bottom-up, middle-down and top-down approaches and their suitability for his work in clinical support versus research and discovery.

The new frontier: using LC–MS/MS for quantitative assays to support gene therapies

<description>Breaking down barriers for women in tech: an interview with Tina Marshall by Future Science Group</description>

Breaking down barriers for women in tech: an inte…

Breaking down barriers for women in tech: an interview with Tina Marshall by Future Science Group

Breaking down barriers for women in tech: an interview with Tina Marshall

<description>What disparities exist in cancer screening and how does this impact patient outcomes? Listen to our latest podcast episode with Kilan Ashad-Bishop (American Cancer Society) to find out about the intersection between science, health, and society.</description>

What disparities exist in cancer screening and ho…

What disparities exist in cancer screening and how does this impact patient outcomes? Listen to our latest podcast episode with Kilan Ashad-Bishop (American Cancer Society) to find out about the intersection between science, health, and society.

Uncovering the link between cancer disparities and climate change

<description>AI-driven early disease detection: an interview with Jim Kean by Future Science Group</description>

AI-driven early disease detection: an interview w…

AI-driven early disease detection: an interview with Jim Kean by Future Science Group

AI-driven early disease detection: an interview with Jim Kean

<description>In this episode, we spoke to Senior Director Johanna Mora about her experience with immunogenicity testing for cell and gene therapies (CGTs) and how she prepared for the expansion of BMS's portfolio to include CGTs. We discuss the importance of having diverse teams with a broad range of experiences to solve complex problems, as well as the role of artificial intelligence in improving our efficiency and spotting patterns in the data.</description>

In this episode, we spoke to Senior Director Joha…

In this episode, we spoke to Senior Director Johanna Mora about her experience with immunogenicity testing for cell and gene therapies (CGTs) and how she prepared for the expansion of BMS's portfolio to include CGTs. We discuss the importance of having diverse teams with a broad range of experiences to solve complex problems, as well as the role of artificial intelligence in improving our efficiency and spotting patterns in the data.

Future Science Group

Details

Recent Episodes